ITEM 2.01
COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
On September 24, 2018, pursuant to the Agreement and Plan of Merger, dated as of September 18, 2018, as (the Merger Plan) by and between Phoenix Life Sciences International Limited, a Nevada Corporation (the Company) and Phoenix Life Sciences International Limited, a Canada Corporation (PLSI CA), the Company completed its merger with PLSI CA, with the Company as the surviving entity. The Merger was effective as of 12:00 AM, September 18, 2018. The Company will issue exchange common stock with PLSI CA shareholders at a 1:1 ratio. As of the effective date of the merger, Russell Stone resigned as Director. Following the effective date of the Merger, Stephen Cornford, Janelle Mardsen, Geoff Boynton and Martin Tindall will be appointed to the Companys Board of Directors, and Martin Tindall will be named the Companys CEO. A copy of the merger plan is attached hereto as Exhibit 2.1. The information in this Item 2.01 and the exhibit attached hereto are furnished to, but not filed with, the Securities and Exchange Commission.
